Last reviewed · How we verify
Toronto association — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Toronto association (Toronto association) — EMS. Toronto association drug is used to treat various conditions by modulating the immune system.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Toronto association TARGET | Toronto association | EMS | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Toronto association CI watch — RSS
- Toronto association CI watch — Atom
- Toronto association CI watch — JSON
- Toronto association alone — RSS
Cite this brief
Drug Landscape (2026). Toronto association — Competitive Intelligence Brief. https://druglandscape.com/ci/toronto-association. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab